H-1339

H-1339

Cat.No.: CSC-C0516

Species: Homo sapiens (Human)

Source: Pleural Effusion Metastasis

Morphology: adherent epitheloid cells growing in monolayers

Culture Properties: monolayer

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C0516
Description
Established from the pleural effusion of a 49-year-old white woman in 1986 prior to treatment for extensive small cell lung cancer which responded only partially to chemotherapy
Species
Homo sapiens (Human)
Source
Pleural Effusion Metastasis
Recommended Medium
Culture Properties
monolayer
Morphology
adherent epitheloid cells growing in monolayers
Disease
Lung Small Cell Carcinoma
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 1 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
NCI-H1339; H1339; NCIH1339
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer

Cell Reports | DOI | Paper |

Background

Catozzi et al. investigate the ATOH1 molecular subtype of small cell lung cancer (SCLC). ATOH1 protein was detected in a minority of preclinical models and clinical samples, often co-expressed with NEUROD1 and occasionally ASCL1. In circulating tumor cell-derived explant models, ATOH1 directly regulates neurogenesis and differentiation programs. ATOH1 is required for cell survival ex vivo, and its depletion slows tumor growth and suppresses liver metastasis in vivo. These findings validate ATOH1 as a lineage-defining transcription factor with pro-tumorigenic and pro-metastatic functions in SCLC.

Key Findings

ATOH1 defines a transcriptionally distinct SCLC subtype detected in 7/81 preclinical models and 16/102 clinical samples, alone or with ASCL1/NEUROD1. ATOH1-expressing CDX models are chemoresistant, aggressive, and harbor MYCL amplification/overexpression. ChIP-seq and RNA-seq show ATOH1 binds E-box motifs at promoters and distal regulatory regions, directly regulating neurogenesis, neuronal differentiation, and inner ear hair cell-like programs, with conserved target genes across CDX, PDX, and patient tumors. ATOH1 depletion reduces cell viability and induces caspase-3-independent cell death in ex vivo cultures, and delays subcutaneous tumor growth in vivo. In metastasis assays, ATOH1 knockdown suppresses liver metastatic dissemination and prolongs survival, with residual metastases showing selective pressure to retain/re-express ATOH1. The study establishes ATOH1 as a bona fide lineage-defining TF that supports SCLC cell survival, tumor growth, and liver metastasis, suggesting subtype-specific vulnerabilities.

Contribution

Creative Bioarray supplied the H1339 human SCLC cell line (Cat# CSC-C0516; RRID:CVCL_A472). This validated cell line was cultured under standard conditions and used as an established SCLC model in the study, supporting comparative analyses of SCLC cell lines and experimental assays.

ATOH1 depletion decreases tumor growth kinetics and metastasis in vivo
Fig. 1. ATOH1 depletion decreases tumor growth kinetics and metastasis in vivo

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products